Literature DB >> 31699753

Nearly Complete Genome Sequences of 17 Enterovirus D68 Strains from Kansas City, Missouri, 2018.

Suman B Pakala1, Yi Tan1, Ferdaus Hassan2, Annie Mai1, Robert H Markowitz1, Meghan H Shilts1, Seesandra V Rajagopala1, Rangaraj Selvarangan2,3, Suman R Das4,5.   

Abstract

Here, we report 17 nearly complete genome sequences of enterovirus D68 (EV-D68) isolated from Kansas City, MO, in 2018. Phylogenetic analysis suggests that these strains belong to subclade B3, similar to the ones that caused the 2016 epidemics in the United States but different from the 2014 outbreak B1 strains.
Copyright © 2019 Pakala et al.

Entities:  

Year:  2019        PMID: 31699753      PMCID: PMC6838611          DOI: 10.1128/MRA.00388-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Enterovirus D68 (EV-D68) belongs to the genus Enterovirus in the family Picornaviridae, with a single positive-strand RNA genome of ∼7.5 kb in length coding for 4 structural proteins (VP1 to VP4) and 7 nonstructural proteins (2A to 2C and 3A to 3D) (1). EV-D68 was first isolated in California in 1962 from patients with bronchiolitis and pneumonia (2). Between 1962 and 2014, EV-D68 was sporadically detected in different parts of the world (3, 4). However, in August 2014, a new subclade of EV-D68, B1, caused a nationwide outbreak in the United States and an increased number of acute flaccid myelitis (AFM) cases (5, 6). In 2016, a different subclade of EV-D68 strains, B3, spread in some states, such as New York and Missouri, and caused local epidemics (Fig. 1) (7, 8). EV-D68 continues to spread sporadically and was reported in Europe, with more AFM cases involved, in 2018 (9, 10).
FIG 1

We combined the 17 newly acquired complete EV-D68 genome sequences collected in 2018 in Kansas City with EV-D68 genome sequences available in GenBank (as of 31 January 2019) and generated a data set with a total of 628 complete genome sequences of EV-D68. Sequences were aligned using the MUSCLE program in MEGA6, with manual adjustments (15). The global phylogenetic tree of EV-D68 was inferred using the neighbor-joining method conducted in MEGA6, with the Kimura 2-parameter test and bootstrap test of 1,000 replicates (16). The tree is midpoint rooted and drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Well-supported nodes by bootstrap values over 70% are shown next to the branches. Six major clades/subclades (B1, B2, B3, C, A1, and A2) are described in the tree. New 2018 sequences sampled from Kansas City are marked in the tree as well.

We combined the 17 newly acquired complete EV-D68 genome sequences collected in 2018 in Kansas City with EV-D68 genome sequences available in GenBank (as of 31 January 2019) and generated a data set with a total of 628 complete genome sequences of EV-D68. Sequences were aligned using the MUSCLE program in MEGA6, with manual adjustments (15). The global phylogenetic tree of EV-D68 was inferred using the neighbor-joining method conducted in MEGA6, with the Kimura 2-parameter test and bootstrap test of 1,000 replicates (16). The tree is midpoint rooted and drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Well-supported nodes by bootstrap values over 70% are shown next to the branches. Six major clades/subclades (B1, B2, B3, C, A1, and A2) are described in the tree. New 2018 sequences sampled from Kansas City are marked in the tree as well. Previously, we had developed a high-throughput complete genome sequencing pipeline for EV-D68 to describe the early outbreak of EV-D68 in Kansas City, MO, in 2014 (11). Here, we report the genome sequence of EV-D68, which was obtained from 17 patients from Kansas City between August and October 2018. EV-D68 was confirmed by quantitative PCR (qPCR) (12). After RNA extraction, full-length cDNA was reverse transcribed with the first-strand synthesis SuperMix kit. Two overlapping amplicons (a small [S] 904-bp and large [L] 6.8-kbp amplicon) were generated using EV-D68-specific primers, as described before (11). Libraries were constructed with the NEBNext Ultra II FS DNA kit, samples were pooled, and sequencing was performed using an Illumina MiSeq instrument with 2 × 250-bp reads. The median number of reads generated per sample was 376,488 (interquartile range [IQR], 326,864 to 421,360 reads). Sequencing reads were binned by barcode, adapters were trimmed with Cutadapt (v 1.18) (13), and low-quality bases were removed with Trimmomatic (v 0.36) (14). Reads were normalized using BBTools (v 38.34) (14) and initially assembled de novo using the SPAdes assembler (v 3.13.0) (15), using default parameters. BLASTN searches of the resulting contigs identified an EV-D68 isolate from 2016, with GenBank accession number KY385889 (enterovirus D68 isolate NY212_16, complete genome), as the closest match. Using this sequence as a reference, consensus sequences were produced for all 17 samples using CLC Genomics Workbench (v 11.0.1), with length and similarity fraction thresholds set at 0.9. The average depth of coverage varied between 224× and 4,228×. All 17 sequences are 7,331 bp in length, and their G+C contents vary between 41.6% and 41.9%. They were annotated using the VAPiD annotation pipeline (v 1.6.2) (16) and submitted to GenBank. Although these 17 2018 EV-D68 isolates from Kansas City belonged to the B3 subclade, phylogenetic analysis shows that they did not cluster with the strains that caused the 2016 epidemics in the United States and Europe (∼98.21% similarity) or the strains reported in Europe (France) in 2018 (∼97.93% similarity), which also are in subclade B3 (Fig. 1). The similarity between the 2018 Kansas City EV-D68 strains and the 2014 outbreak B1 subclade was ∼94.83%. These are the first publicly available EV-D68 genome sequences collected in the United States during the 2018 epidemics. With the increasing number of AFM cases related to EV-D68 infection, our newly reported 2018 EV-D68 strains could help us understand the epidemiological dynamics and clinical implications of EV-D68 in the United States and globally.

Data availability.

All sequences were submitted to GenBank with accession numbers MK659588 to MK659604. All raw reads were submitted to SRA. The published SRA submission can be found at BioProject accession number PRJNA532464.
  15 in total

1.  Enterovirus surveillance--United States, 1970-2005.

Authors:  Nino Khetsuriani; Ashley Lamonte-Fowlkes; Steven Oberst; Mark A Pallansch
Journal:  MMWR Surveill Summ       Date:  2006-09-15

2.  Commentary. Severe Respiratory Illness Associated With Enterovirus D68—Missouri and Illinois, 2014.

Authors:  Mark T Steele; Irene Walsh
Journal:  Ann Emerg Med       Date:  2015-03       Impact factor: 5.721

3.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.

Authors:  M Kimura
Journal:  J Mol Evol       Date:  1980-12       Impact factor: 2.395

4.  Worldwide emergence of multiple clades of enterovirus 68.

Authors:  Rafal Tokarz; Cadhla Firth; Shabir A Madhi; Stephen R C Howie; Winfred Wu; Amadou Alpha Sall; Saddef Haq; Thomas Briese; W Ian Lipkin
Journal:  J Gen Virol       Date:  2012-06-13       Impact factor: 3.891

5.  Molecular Evolution and Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States.

Authors:  Yi Tan; Ferdaus Hassan; Jennifer E Schuster; Ari Simenauer; Rangaraj Selvarangan; Rebecca A Halpin; Xudong Lin; Nadia Fedorova; Timothy B Stockwell; Tommy Tsan-Yuk Lam; James D Chappell; Tina V Hartert; Edward C Holmes; Suman R Das
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Complete Genome Sequences of Nine Enterovirus D68 Strains from Patients of the Lower Hudson Valley, New York, 2016.

Authors:  Weihua Huang; Changhong Yin; Jian Zhuge; Taliya Farooq; Esther C Yoon; Sheila M Nolan; Donald Chen; John T Fallon; Guiqing Wang
Journal:  Genome Announc       Date:  2016-12-15

7.  Genome Sequence of Enterovirus D68 from St. Louis, Missouri, USA, 2016.

Authors:  Kristine M Wylie; Todd N Wylie; Gregory A Storch
Journal:  Genome Announc       Date:  2017-03-02

8.  Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018.

Authors:  Stephanie A Kujawski; Claire M Midgley; Brian Rha; Joana Y Lively; W Allan Nix; Aaron T Curns; Daniel C Payne; Janet A Englund; Julie A Boom; John V Williams; Geoffrey A Weinberg; Mary A Staat; Rangaraj Selvarangan; Natasha B Halasa; Eileen J Klein; Leila C Sahni; Marian G Michaels; Lynne Shelley; Monica McNeal; Christopher J Harrison; Laura S Stewart; Adriana S Lopez; Janell A Routh; Manisha Patel; M Steven Oberste; John T Watson; Susan I Gerber
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-29       Impact factor: 17.586

9.  An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018-21 January 2019: early findings.

Authors: 
Journal:  Euro Surveill       Date:  2019-02

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more
  2 in total

1.  Biennial Upsurge and Molecular Epidemiology of Enterovirus D68 Infection in New York, USA, 2014 to 2018.

Authors:  Victoria L Gilrane; Jian Zhuge; Weihua Huang; Sheila M Nolan; Abhay Dhand; Changhong Yin; Christian Salib; Faariah Shakil; Helen Engel; John T Fallon; Guiqing Wang
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA.

Authors:  Robyn A Livingston; Christopher J Harrison; Rangaraj Selvarangan
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.